Ivermectin in Dogs & Cats

Ivermectin is a semi-synthetic derivative of the avermectin family of compounds, which were originally isolated from the fermentation products of the soil-dwelling bacterium Streptomyces avermitilis. It serves as a cornerstone antiparasitic treatment in veterinary clinical practice due to its high efficacy and relatively low toxicity at therapeutic doses. Veterinarians prescribe this medication to address various parasitic conditions, ranging from gastrointestinal worms to microscopic skin mites. While it is highly effective, its administration requires careful veterinary oversight because certain genetic mutations in specific dog breeds can make them exceptionally sensitive to the drug's effects. In its application, ivermectin is often compared to newer macrolide endectocides, such as selamectin or milbemycin oxime, which are also frequently used for heartworm prevention. While oral and topical medications like afoxolaner and sarolaner focus primarily on fleas and ticks, ivermectin remains a critical tool for managing complex mange and specific internal nematodes. By disrupting the nerve signals of parasites, it effectively neutralizes infestations that might otherwise cause severe morbidity or mortality in veterinary patients. The clinical management of parasitic diseases has evolved significantly with the introduction of various systemic therapies. Unlike products containing imidacloprid, which are primarily topical and focus on external parasite knockdown, ivermectin offers a systemic approach that travels through the bloodstream to reach parasites residing in deep tissues or the digestive tract. It is frequently employed in multi-modal treatment plans alongside other agents like praziquantel to ensure comprehensive coverage against various helminth species. Practitioners must always tailor the dosage to the species and individual patient requirements to avoid accidental neurotoxicity.